News & Insights

S32 co-led the $30 million financing of Puzzle, an AI-powered accounting solution, to accelerate the future of automated, real-time finance.

Once considered an unorthodox path to going public, direct listings are gaining traction as an alternative to the traditional IPO. On Wednesday, the Securities and Exchange Commission (SEC) approved a rule change, with immediate effect, that will permit companies to raise capital in a direct listing on the Nasdaq Global Select Market.

Gunderson Dettmer partners Ryan Gunderson and Jeff Thacker hosted a discussion on the benefits and considerations of raising capital from crossover funds as part of a post- IPO Summit series of workshops.

Contineum Therapeutics, a clinical-stage biopharmaceutical company, announces the pricing of an upsized underwritten public offering of 7,346,938 shares of its Class A common stock at a public offering price of $12.25 per share.

S32 leads the $11 million Series Seed financing of AI-powered platform designed to judge and referee sporting events, The Owl AI

Biopharmaceutical company, Tarsus Pharmaceuticals, announces its March 2025 upsized underwritten public offering

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP has elected six new partners, effective January 1. The elevations span the U.S. and add to the firm’s corporate and securities, venture and growth equity fund, public offerings/public companies, executive compensation and tax practices.

Chambers & Partners announced its 2015 USA Rankings and the once again Gunderson Dettmer is in the top tier in several practice areas.